
Financials · Reinsurance
$353.59
-0.89%
Vol: 270K
Friday, May 1, 2026
Everest Group posted Q1 net income of $653M (vs $210M YoY), driven by improved 91.2% combined ratio and $567M net investment income. Revenue miss of $4.07B fell short but EPS of $16.21 crushed estimates of $13.98 by 16%. Book value reached $383.75/share with 16.7% annualized operating ROE. Shares jumped 3.1% post-earnings. Bear case: top-line weakness and potential premium pressure in reinsurance markets.
Everest Group reported Q1 2026 net income of $653M or $16.21 diluted EPS, up from $210M or $4.90 year-ago, though revenue missed estimates at $4.07B down 4.6% YoY. The consolidated combined ratio improved to 91.2% from 102.7%, driven by lower catastrophe losses and favorable reserve development. Operating ROE annualized to 16.7%. The company repurchased $331M of shares at $330 average and $100M additional in April. Everest expects meaningful capital release from AIG retail business transition in H2 2026. Stock remained flat at $342.22 post-results.
Everest Group announced a recast financial supplement with new reportable segments (Reinsurance Treaty, Global Wholesale and Specialty, Legacy) following the sale of its Commercial Retail Insurance renewal rights to AIG. Q1 2026 earnings are expected to show EPS of $14.35 (up 122.5% YoY). Wells Fargo lowered price target to $304, while Barclays maintained overweight with $380 target. Two senior appointments announced: Katy Bradica as Group Chief Actuary and Attila Kerenyi as Group Chief Risk Officer.
Everest Group restructured reportable segments effective January 1, 2026 to Reinsurance Treaty, Global Wholesale and Specialty, and Legacy following the sale of Commercial Retail Insurance renewal rights to AIG for approximately $2 billion. Wells Fargo analyst maintained Equal-Weight rating but lowered price target to $304 from $310 on April 9. Leadership changes include Elias Habayeb as EVP and Group CFO effective May 1.
Everest Group published a recast Q4 2025 financial supplement reflecting its strategic pivot away from commercial retail insurance. The company expects a pre-tax non-operating charge of $250M-$350M related to the AIG renewal-rights transaction. Wells Fargo lowered its price target from $310 to $304 while maintaining Equal-Weight rating. Q1 2026 earnings scheduled for April 29-30.
Everest Group stock gained 2.03% during April 11-13, 2026. Analysts expect EPS of $14.35, up 122.5% from $6.45 year-ago. Wells Fargo maintained Equal-Weight with $304 target. Barclays maintained Overweight and raised target to $380. Q1 results due April 29.
Everest Group preparing Q1 2026 earnings on April 29 with analysts expecting EPS of $14.35, up 122.5% YoY. Barclays raised price target to $380 on April 8, maintaining Overweight. Wells Fargo lowered target to $304 on April 9. Analyst consensus: 5 Strong Buy, 2 Moderate Buy, 11 Hold, 1 Strong Sell with average target $362.56.
Everest Group announced definitive agreements to sell Global Retail Commercial Insurance renewal rights (~$2B GWP) to AIG plus $1.2B adverse development cover. Strategic shift sharpens focus on core Reinsurance and Global Wholesale/Specialty Insurance. Full-year 2025 net income $1.6B, NOI $1.9B with GWP $17.7B (−3.1% YoY). Stock rose 2.03%, outpacing broader market. 13 analysts rate Buy with avg price target $370.09, indicating 11.19% upside. Company executing strategic transition, shrinking insurance business 30−40%.
Everest Group reported 2025 net income of $1.6 billion and full-year gross written premium of $17.7 billion. The company is executing strategic transition, shrinking insurance business by 30-40% to focus on higher-quality underwriting. Sale to AIG involves estimated $2 billion of renewal rights. New CEO Jim Williamson appointed effective immediately. According to 13 analysts, average Buy rating with 12-month target of $370.09, indicating 11.19% upside.
No material news in the last 48 hours.
Everest Group announced agreements to sell renewal rights of Global Retail Commercial Insurance business to AIG, totaling estimated $2B aggregate gross premiums written. Strategic refocusing of operations.
Everest Group announced the appointment of Jason Busti as Head of North America Treaty Reinsurance effective April 2, 2026. The company will release Q1 2026 financial results on April 29 after market close. In March, Everest announced an agreement to sell its Canadian retail insurance operations to Wawanesa.
Everest Group announced completion of agreements to sell renewal rights for its Global Retail Commercial Insurance business to AIG, totaling an estimated $2 billion of aggregate gross premiums written. This sharpens focus on core global Reinsurance and Global Wholesale/Specialty Insurance businesses. The company reported full-year 2025 net income of $1.6 billion with net operating income ROE of 12.4%, declared a $2.00 per share dividend, and raised FY 2026 earnings guidance. Stock rose 2.03% on positive earnings expectations.
Everest Group stock rose 2.03% as investors positioned ahead of Q1 2026 earnings (April 29). Executing strategic transition, shrinking insurance business 30-40% to focus on higher-quality underwriting. Recent dividend of $2.00 per share paid March 27.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| EGEVEREST | $353.59 | -0.89% | +8.6% | 5.9x | 0.33 | $14.3B |
| BRK.BBERKSHIRE | $474.00 | +0.08% | -0.6% | 21.8x | 0.70 | $1.02T |
| JPMJPMORGAN | $313.11 | -0.04% | +6.0% | 13.3x | 1.04 | $839.3B |
| VVISA | $328.42 | -0.43% | +8.7% | 22.5x | — | $627.4B |
| MAMASTERCARD | $495.68 | -1.44% | +0.3% | 22.2x | 0.83 | $444.8B |
| BACBANK | $53.33 | -0.25% | +6.8% | 10.6x | 1.24 | $381.2B |
Price above both MAs — bullish structure.